ADR.ppt pharmacilogy ppt of adverse drug reactionSuma Lakavath
油
This document discusses adverse drug reactions (ADRs), including definitions, classifications, types, and prevention. It defines an ADR as any noxious change suspected to be caused by a drug at normal doses. ADRs can be classified based on timing (immediate vs. prolonged use), severity (minor to lethal), and type (predictable vs. unpredictable). Common types include augmented, bizarre, chronic, delayed, ending use, and failure of efficacy reactions. High risk groups for ADRs include the elderly, children, and those with multiple diseases or medications. Pharmacovigilance aims to detect, assess, and prevent ADRs through postmarketing surveillance.
ADR.ppt arverse drug reactions power ptSuma Lakavath
油
This document discusses adverse drug reactions (ADRs), including definitions, classifications, and prevention. It defines an ADR as a noxious change suspected to be caused by a drug used at normal doses. ADRs can be classified as Type A (predictable) or Type B (unpredictable) reactions. Type A reactions are dose-dependent while Type B reactions involve immune responses. The document also discusses drug interactions, teratogenicity, pharmacovigilance systems for monitoring ADRs, and provides examples of common ADRs for different drug classes.
This document discusses adverse drug reactions and pharmacovigilance. It defines adverse drug reactions as noxious changes suspected to be caused by a drug. Adverse drug reactions are classified based on their timing (immediate, delayed), severity (minor to lethal), predictability (type A - dose-dependent and type B - unpredictable), and other characteristics. The document also discusses preventing adverse reactions through appropriate drug use and monitoring patients for new symptoms after starting treatment. Pharmacovigilance aims to detect, understand and prevent adverse drug reactions through postmarketing surveillance.
This document discusses adverse drug reactions (ADRs). It defines ADRs as noxious changes suspected to be caused by a drug. It notes the incidence of ADRs is higher in populations like the elderly, children, and pregnant women. ADRs can develop immediately or after prolonged medication use, and are classified based on their severity from minor to lethal. The document also categorizes ADRs and discusses types like augmented, bizarre, chronic, delayed, and ending drug use. It covers topics such as pharmacovigilance, preventing ADRs, drug interactions, and classifications including side effects, toxicity, intolerance, and idiosyncrasy.
This document discusses adverse drug reactions (ADRs). It defines ADRs as noxious changes suspected to be caused by a drug. It notes the incidence is higher in populations like the elderly, children, and immunosuppressed individuals. ADRs can develop immediately or after prolonged medication use, and are graded based on their severity. ADRs are broadly classified as Type A (predictable) or Type B (unpredictable). It also discusses concepts like idiosyncrasy, allergy, dependence, withdrawal, teratogenicity, and pharmacovigilance monitoring of ADRs.
GRADING OF SEVERITY OF ADVERSE DRUG REACTIONS.pptkaromemmanuel2
油
ADVERSE DRUG REACTION Any noxious change which is
Suspected to be due to a drug
At doses normally used in man
May requires treatment or decrease in dose or
Caution in the future use of the same drug
This document discusses adverse drug reactions (ADRs), their classification and prevention. It defines ADRs as noxious changes caused by drugs taken at normal doses. ADRs are classified as type A (predictable, dose-dependent) or type B (unpredictable, immune-mediated). It also describes various types of ADRs including augmented, bizarre, continuous, delayed, ending use and failure of efficacy reactions. The document emphasizes the importance of pharmacovigilance in detecting, understanding and preventing ADRs through activities like monitoring, data analysis and issuing safety guidelines. It concludes with examples of preventing ADRs through rational drug use and always considering ADRs when new symptoms arise during treatment.
This document discusses adverse drug reactions and events. It defines an adverse drug reaction as an unwanted change suspected to be caused by a drug. Adverse drug events may occur during treatment but are not necessarily caused by the treatment. Certain populations like the elderly, children, and immunosuppressed individuals are more susceptible to adverse drug reactions. Reactions can occur immediately or be delayed. They are classified and graded based on their severity and predictability. Pharmacovigilance aims to detect, understand, and prevent adverse drug problems.
This document discusses adverse drug reactions (ADRs). It defines an ADR as an unwanted change caused by a drug taken at normal doses. ADRs can range from minor to severe/lethal. They are classified based on timing (immediate vs. delayed), mechanism (predictable type A vs. unpredictable type B), chronicity, and severity. High-risk groups for ADRs include the elderly, children, and those with multiple illnesses or medications. Pharmacovigilance aims to detect, understand, and prevent ADRs through postmarketing surveillance. The Uppsala Monitoring Centre in Sweden coordinates international pharmacovigilance efforts.
This document discusses adverse drug reactions (ADRs), including definitions, classifications, mechanisms, risk factors, and prevention strategies. It defines ADRs as noxious changes suspected to be caused by a drug. ADRs can be classified as type A (predictable, dose-related) or type B (unpredictable, immune-mediated). Risk factors for ADRs include polypharmacy, older age, multiple illnesses, and malnutrition. Prevention strategies include appropriate dosing, monitoring for new symptoms, and considering drug interactions and patient history. The document also covers topics like drug dependence, teratogenicity, and the role of pharmacovigilance in monitoring ADRs.
Adverse drug reactions (ADRs) are any noxious, unintended changes in the body which occur at normal dosages of a drug. ADRs can be caused by drugs' intended pharmacological effects or unpredictable reactions. They are a major issue due to polypharmacy, the elderly, children, and immunosuppressed patients being more susceptible. ADRs are classified based on timing (immediate, delayed), severity (minor to lethal), predictability (type A-pharmacological, type B-immunological), and chronicity. Preventing ADRs involves appropriate drug use, monitoring for reactions, and being aware patients' medical histories and laboratory values can increase risks.
General Adverse Drug reactions of drugs.Udaya Vignesh
油
This Above 際際滷 show gives an Comprehensive Data about the Adverse drug reactions of a drug... example Type A and Type B.. And it has many More types of the Adverse drug reactions Example the Type A means augmented which Means the Normal Action of the Drug is augmented example if u are taking insulin whos normal action is to decrease the blood glucose what will happen if u take it an very high dose it will cause an High amount of the Hypoglycemia which can lead to sweating palpitations and Many more symptoms just like this
The document discusses various types of adverse drug reactions (ADRs) and events. It defines an ADR as any noxious change suspected to be caused by a drug taken at normal doses, and an adverse drug event as any untoward occurrence during treatment that may not be causally related. It describes types of ADRs including dose-related type A reactions, unpredictable type B reactions, chronic type C reactions, and withdrawal type E reactions. It also discusses factors influencing ADRs, grading of severity, classifications, mechanisms of hypersensitivity reactions, pharmacovigilance, and prevention of adverse effects.
This document discusses adverse drug reactions and pharmacovigilance. It defines an adverse drug reaction as an unwanted change caused by a drug at normal doses that requires treatment or a dose decrease. Adverse drug events are untoward occurrences during treatment that are not necessarily caused by the treatment. The document classifies adverse drug reactions into types A, B, C, D and E based on factors like dose, time of onset, and mechanism. It also discusses preventing adverse drug effects through appropriate use and monitoring for new symptoms after starting treatment. Pharmacovigilance aims to detect, understand and prevent adverse drug reactions through postmarketing surveillance.
ADE
INCIDENCE OF ADR
GREADING OF SEVERITY OF ADR
CLASSIFICATIONS
PHARMACOVIGILANCE
CATAGORIES
CAUSES OF ADR
DRUG INDUCED HEPATIC DYSFUNCTION
DRUG INDUCED ENDOCRINE DYSFUNCTION
DRUG INDUCED PHERIPHERAL NEUROPATHY
MANAGEMENT OF ADR
This document discusses adverse drug reactions and events. It defines adverse drug reactions as unintended responses to drugs that occur at therapeutic doses. Adverse drug events may or may not be caused by the drug. Factors that increase risk of adverse reactions include polypharmacy, aging, pregnancy, and immunosuppression. Reactions are classified based on severity from minor to lethal. Type A reactions are predictable and dose-dependent while Type B reactions involve immune responses and are unpredictable. Preventing adverse reactions involves appropriate use of drugs and monitoring for new symptoms after starting treatment.
This document discusses adverse drug reactions (ADRs), defined as any noxious change suspected to be caused by a drug. It provides definitions of key terms like adverse event and adverse drug event. It also categorizes different types of ADRs based on factors like onset, reaction type, severity, and more. Examples are given for each category to illustrate different types of ADRs like augmented, bizarre, chemical, delayed, and others. The document discusses concepts like side effects, secondary effects, toxic effects, intolerance, idiosyncrasy, drug allergy, and more.
The document discusses adverse drug reactions (ADRs). It defines an ADR as an undesirable effect from drug administration. ADRs can range from trivial to fatal and exclude overdoses or poisonings. An adverse drug event is any untoward medical occurrence during treatment that may not have a causal relationship. The epidemiology section notes ADRs are a leading cause of death in hospitals, with estimates of 6.7% incidence of serious ADRs and 0.3-7% of hospital admissions due to ADRs. Risk is higher in the elderly, children, and those with multiple diseases or medications. ADRs can be classified as type A, predictable effects, or type B, unpredictable immunological reactions
The document discusses adverse drug reactions (ADRs). It defines ADRs and different types including: Type A reactions which are augmented/predictable effects; Type B which are bizarre/unpredictable; Type C seen with continuous use; Type D which are delayed effects; Type E occurring at the end of a dose; and Type F resulting from treatment failure. It provides examples and management strategies for each type of ADR.
The document defines adverse drug reactions (ADRs) and describes the different types and classifications of ADRs. It states that according to WHO, an ADR is an unintended or unwanted effect of a drug that occurs at standard therapeutic doses. The document then outlines various factors that can influence ADRs like age, sex, dosage, and genetic factors. It describes the different types of ADRs as Type A, B, C, D and E reactions and provides examples of each type. Finally, it discusses methods of assessing ADR severity and causality.
Drugs can have both beneficial and harmful effects. While drugs save lives and improve health, they can also threaten life. It is important to consider whether the potential benefits of a medication outweigh the risks for a given individual. Adverse drug reactions (ADRs) are a common clinical problem that can have serious consequences for patients, including death. Anyone taking medication can experience an ADR, but some groups are at higher risk, such as the elderly, those taking multiple drugs, and those with multiple medical conditions. Proper diagnosis and management of ADRs is important to prevent further harm.
This document provides information on adverse drug reactions (ADRs), including:
1. It defines ADRs and differentiates them from adverse drug events, and outlines some common causes of events that are excluded from being considered ADRs.
2. It describes various types and classifications of ADRs, including by intensity/severity, outcome, mechanism of production, and pharmacoepidemiological criteria.
3. It discusses methods of pharmacovigilance for detecting ADRs and standards for determining the imputability or likelihood that a reaction was caused by a drug.
This document discusses adverse drug reactions (ADRs). It defines ADRs and provides statistics on their frequency and impact. It discusses various factors that can influence ADRs, including patient characteristics like age and genetics. It also discusses drug properties and interactions that can lead to ADRs. The document classifies ADRs into types A-F based on mechanisms and timing. It provides many examples of common and serious ADRs to illustrate different types. The document emphasizes the importance of pharmacovigilance in monitoring and preventing ADRs.
Adverse drug reaction and adverse drug eventssuser7add2a
油
This document discusses adverse drug reactions (ADRs), defined as harmful or unpleasant reactions resulting from medication use. It describes different types of ADRs including type A (predictable) dose-dependent reactions and type B (unpredictable) reactions related to immunity or genetics. It also discusses factors that increase ADR risk like polypharmacy, age, and disease status. The document outlines methods for classifying, grading, and preventing ADRs, and the role of pharmacovigilance in monitoring drug safety post-marketing.
The document discusses various types of adverse drug reactions (ADRs), including:
1. Predictable (Type A) reactions which are dose-dependent and based on the drug's pharmacological properties. These occur in normal patients and account for 80% of ADRs.
2. Unpredictable (Type B) reactions which are idiosyncratic, dose-independent, and related to the patient's peculiarities or immune response. These are less common but more serious.
3. Factors that influence the risk of ADRs like polypharmacy, use in elderly patients, prolonged drug therapy, and individual patient variability. Close monitoring is important to prevent adverse outcomes from medication.
An adverse drug reaction (ADR) is an unwanted or harmful reaction that occurs when taking a medication. ADRs can range from mild to severe or life-threatening. They are classified based on their cause and severity. Serious ADRs are those that result in death, are life-threatening, cause hospitalization or disability, or require intervention to prevent impairment or damage. Managing ADRs involves withdrawing the drug if possible and treating the effects. All suspected ADRs should be reported to help monitor drug safety.
This document discusses adverse drug reactions (ADRs), their classification and prevention. It defines ADRs as noxious changes caused by drugs taken at normal doses. ADRs are classified as type A (predictable, dose-dependent) or type B (unpredictable, immune-mediated). It also describes various types of ADRs including augmented, bizarre, continuous, delayed, ending use and failure of efficacy reactions. The document emphasizes the importance of pharmacovigilance in detecting, understanding and preventing ADRs through activities like monitoring, data analysis and issuing safety guidelines. It concludes with examples of preventing ADRs through rational drug use and always considering ADRs when new symptoms arise during treatment.
This document discusses adverse drug reactions and events. It defines an adverse drug reaction as an unwanted change suspected to be caused by a drug. Adverse drug events may occur during treatment but are not necessarily caused by the treatment. Certain populations like the elderly, children, and immunosuppressed individuals are more susceptible to adverse drug reactions. Reactions can occur immediately or be delayed. They are classified and graded based on their severity and predictability. Pharmacovigilance aims to detect, understand, and prevent adverse drug problems.
This document discusses adverse drug reactions (ADRs). It defines an ADR as an unwanted change caused by a drug taken at normal doses. ADRs can range from minor to severe/lethal. They are classified based on timing (immediate vs. delayed), mechanism (predictable type A vs. unpredictable type B), chronicity, and severity. High-risk groups for ADRs include the elderly, children, and those with multiple illnesses or medications. Pharmacovigilance aims to detect, understand, and prevent ADRs through postmarketing surveillance. The Uppsala Monitoring Centre in Sweden coordinates international pharmacovigilance efforts.
This document discusses adverse drug reactions (ADRs), including definitions, classifications, mechanisms, risk factors, and prevention strategies. It defines ADRs as noxious changes suspected to be caused by a drug. ADRs can be classified as type A (predictable, dose-related) or type B (unpredictable, immune-mediated). Risk factors for ADRs include polypharmacy, older age, multiple illnesses, and malnutrition. Prevention strategies include appropriate dosing, monitoring for new symptoms, and considering drug interactions and patient history. The document also covers topics like drug dependence, teratogenicity, and the role of pharmacovigilance in monitoring ADRs.
Adverse drug reactions (ADRs) are any noxious, unintended changes in the body which occur at normal dosages of a drug. ADRs can be caused by drugs' intended pharmacological effects or unpredictable reactions. They are a major issue due to polypharmacy, the elderly, children, and immunosuppressed patients being more susceptible. ADRs are classified based on timing (immediate, delayed), severity (minor to lethal), predictability (type A-pharmacological, type B-immunological), and chronicity. Preventing ADRs involves appropriate drug use, monitoring for reactions, and being aware patients' medical histories and laboratory values can increase risks.
General Adverse Drug reactions of drugs.Udaya Vignesh
油
This Above 際際滷 show gives an Comprehensive Data about the Adverse drug reactions of a drug... example Type A and Type B.. And it has many More types of the Adverse drug reactions Example the Type A means augmented which Means the Normal Action of the Drug is augmented example if u are taking insulin whos normal action is to decrease the blood glucose what will happen if u take it an very high dose it will cause an High amount of the Hypoglycemia which can lead to sweating palpitations and Many more symptoms just like this
The document discusses various types of adverse drug reactions (ADRs) and events. It defines an ADR as any noxious change suspected to be caused by a drug taken at normal doses, and an adverse drug event as any untoward occurrence during treatment that may not be causally related. It describes types of ADRs including dose-related type A reactions, unpredictable type B reactions, chronic type C reactions, and withdrawal type E reactions. It also discusses factors influencing ADRs, grading of severity, classifications, mechanisms of hypersensitivity reactions, pharmacovigilance, and prevention of adverse effects.
This document discusses adverse drug reactions and pharmacovigilance. It defines an adverse drug reaction as an unwanted change caused by a drug at normal doses that requires treatment or a dose decrease. Adverse drug events are untoward occurrences during treatment that are not necessarily caused by the treatment. The document classifies adverse drug reactions into types A, B, C, D and E based on factors like dose, time of onset, and mechanism. It also discusses preventing adverse drug effects through appropriate use and monitoring for new symptoms after starting treatment. Pharmacovigilance aims to detect, understand and prevent adverse drug reactions through postmarketing surveillance.
ADE
INCIDENCE OF ADR
GREADING OF SEVERITY OF ADR
CLASSIFICATIONS
PHARMACOVIGILANCE
CATAGORIES
CAUSES OF ADR
DRUG INDUCED HEPATIC DYSFUNCTION
DRUG INDUCED ENDOCRINE DYSFUNCTION
DRUG INDUCED PHERIPHERAL NEUROPATHY
MANAGEMENT OF ADR
This document discusses adverse drug reactions and events. It defines adverse drug reactions as unintended responses to drugs that occur at therapeutic doses. Adverse drug events may or may not be caused by the drug. Factors that increase risk of adverse reactions include polypharmacy, aging, pregnancy, and immunosuppression. Reactions are classified based on severity from minor to lethal. Type A reactions are predictable and dose-dependent while Type B reactions involve immune responses and are unpredictable. Preventing adverse reactions involves appropriate use of drugs and monitoring for new symptoms after starting treatment.
This document discusses adverse drug reactions (ADRs), defined as any noxious change suspected to be caused by a drug. It provides definitions of key terms like adverse event and adverse drug event. It also categorizes different types of ADRs based on factors like onset, reaction type, severity, and more. Examples are given for each category to illustrate different types of ADRs like augmented, bizarre, chemical, delayed, and others. The document discusses concepts like side effects, secondary effects, toxic effects, intolerance, idiosyncrasy, drug allergy, and more.
The document discusses adverse drug reactions (ADRs). It defines an ADR as an undesirable effect from drug administration. ADRs can range from trivial to fatal and exclude overdoses or poisonings. An adverse drug event is any untoward medical occurrence during treatment that may not have a causal relationship. The epidemiology section notes ADRs are a leading cause of death in hospitals, with estimates of 6.7% incidence of serious ADRs and 0.3-7% of hospital admissions due to ADRs. Risk is higher in the elderly, children, and those with multiple diseases or medications. ADRs can be classified as type A, predictable effects, or type B, unpredictable immunological reactions
The document discusses adverse drug reactions (ADRs). It defines ADRs and different types including: Type A reactions which are augmented/predictable effects; Type B which are bizarre/unpredictable; Type C seen with continuous use; Type D which are delayed effects; Type E occurring at the end of a dose; and Type F resulting from treatment failure. It provides examples and management strategies for each type of ADR.
The document defines adverse drug reactions (ADRs) and describes the different types and classifications of ADRs. It states that according to WHO, an ADR is an unintended or unwanted effect of a drug that occurs at standard therapeutic doses. The document then outlines various factors that can influence ADRs like age, sex, dosage, and genetic factors. It describes the different types of ADRs as Type A, B, C, D and E reactions and provides examples of each type. Finally, it discusses methods of assessing ADR severity and causality.
Drugs can have both beneficial and harmful effects. While drugs save lives and improve health, they can also threaten life. It is important to consider whether the potential benefits of a medication outweigh the risks for a given individual. Adverse drug reactions (ADRs) are a common clinical problem that can have serious consequences for patients, including death. Anyone taking medication can experience an ADR, but some groups are at higher risk, such as the elderly, those taking multiple drugs, and those with multiple medical conditions. Proper diagnosis and management of ADRs is important to prevent further harm.
This document provides information on adverse drug reactions (ADRs), including:
1. It defines ADRs and differentiates them from adverse drug events, and outlines some common causes of events that are excluded from being considered ADRs.
2. It describes various types and classifications of ADRs, including by intensity/severity, outcome, mechanism of production, and pharmacoepidemiological criteria.
3. It discusses methods of pharmacovigilance for detecting ADRs and standards for determining the imputability or likelihood that a reaction was caused by a drug.
This document discusses adverse drug reactions (ADRs). It defines ADRs and provides statistics on their frequency and impact. It discusses various factors that can influence ADRs, including patient characteristics like age and genetics. It also discusses drug properties and interactions that can lead to ADRs. The document classifies ADRs into types A-F based on mechanisms and timing. It provides many examples of common and serious ADRs to illustrate different types. The document emphasizes the importance of pharmacovigilance in monitoring and preventing ADRs.
Adverse drug reaction and adverse drug eventssuser7add2a
油
This document discusses adverse drug reactions (ADRs), defined as harmful or unpleasant reactions resulting from medication use. It describes different types of ADRs including type A (predictable) dose-dependent reactions and type B (unpredictable) reactions related to immunity or genetics. It also discusses factors that increase ADR risk like polypharmacy, age, and disease status. The document outlines methods for classifying, grading, and preventing ADRs, and the role of pharmacovigilance in monitoring drug safety post-marketing.
The document discusses various types of adverse drug reactions (ADRs), including:
1. Predictable (Type A) reactions which are dose-dependent and based on the drug's pharmacological properties. These occur in normal patients and account for 80% of ADRs.
2. Unpredictable (Type B) reactions which are idiosyncratic, dose-independent, and related to the patient's peculiarities or immune response. These are less common but more serious.
3. Factors that influence the risk of ADRs like polypharmacy, use in elderly patients, prolonged drug therapy, and individual patient variability. Close monitoring is important to prevent adverse outcomes from medication.
An adverse drug reaction (ADR) is an unwanted or harmful reaction that occurs when taking a medication. ADRs can range from mild to severe or life-threatening. They are classified based on their cause and severity. Serious ADRs are those that result in death, are life-threatening, cause hospitalization or disability, or require intervention to prevent impairment or damage. Managing ADRs involves withdrawing the drug if possible and treating the effects. All suspected ADRs should be reported to help monitor drug safety.
This document outlines pharmacy practice legislation, challenges, and lessons learned from natural disasters. It reviews legislation supporting pharmacists' roles in disaster response, including prescribing emergency supplies and initiating prescriptions. It outlines challenges faced by pharmacists, such as ensuring medication access. Lessons identified include establishing disaster response plans and knowledge transfer through guidance documents.
The document discusses standards and guidelines for medication management and use (MMU) from the Joint Commission International (JCI). It covers 16 total chapters organized under patient centered, organization management, and academic medical center hospital standards. Specifically, it discusses guidelines for medication storage, ordering, dispensing, administration, and monitoring. Key aspects include safe storage of medications, proper dispensing processes, formulary management, medication reconciliation, handling of narcotics, medication ordering and administration procedures, and reporting of medication errors.
Medication safety is important to prevent patient harm from errors. Factors that contribute to errors include inadequate medication histories, lack of communication between providers, ambiguous labeling, and failure to double check medications. Efforts to improve safety include using generic names, tailoring prescriptions to each patient, knowing high-risk medications, developing checking habits, and encouraging patient involvement in their own care.
This document provides an overview of pharmacy services at Nepal Mediciti Hospital. It describes the pharmacy department structure and roles. Key responsibilities include procuring medicines, dispensing prescriptions, managing inventory and returns. Pharmacy aims to provide quality healthcare products and counseling. It operates 24/7 IP, OP and OT pharmacies. Strict protocols are followed for dispensing, storage, narcotics, high risk drugs and returns. Prescription handling, dispensing processes and inventory management are computerized for accuracy and safety.
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Ganapathi Vankudoth
油
A complete information of Inflammation, it includes types of Inflammation, purpose of Inflammation, pathogenesis of acute inflammation, chemical mediators in inflammation, types of chronic inflammation, wound healing and Inflammation in skin repair, phases of wound healing, factors influencing wound healing and types of wound healing.
This presentation provides a detailed exploration of the morphological and microscopic features of pneumonia, covering its histopathology, classification, and clinical significance. Designed for medical students, pathologists, and healthcare professionals, this lecture differentiates bacterial vs. viral pneumonia, explains lobar, bronchopneumonia, and interstitial pneumonia, and discusses diagnostic imaging patterns.
Key Topics Covered:
Normal lung histology vs. pneumonia-affected lung
Morphological changes in lobar, bronchopneumonia, and interstitial pneumonia
Microscopic features: Fibroblastic plugs, alveolar septal thickening, inflammatory cell infiltration
Stages of lobar pneumonia: Congestion, Red hepatization, Gray hepatization, Resolution
Common causative pathogens (Streptococcus pneumoniae, Klebsiella pneumoniae, Mycoplasma, etc.)
Clinical case study with diagnostic approach and differentials
Who Should Watch?
This is an essential resource for medical students, pathology trainees, and respiratory health professionals looking to enhance their understanding of pneumonias morphological aspects.
Dr. Vincenzo Giordano began his medical career 2011 at Aberdeen Royal Infirmary in the Department of Cardiothoracic Surgery. Here, he performed complex adult cardiothoracic surgical procedures, significantly enhancing his proficiency in patient critical care, as evidenced by his FCCS certification.
FAO's Support Rabies Control in Bali_Jul22.pptxWahid Husein
油
What is FAO doing to support rabies control programmes in Bali, Indonesia, using One Health approach with mass dog vaccination and integrated bite case management as main strategies
Best Sampling Practices Webinar USP <797> Compliance & Environmental Monito...NuAire
油
Best Sampling Practices Webinar USP <797> Compliance & Environmental Monitoring
Are your cleanroom sampling practices USP <797> compliant? This webinar, hosted by Pharmacy Purchasing & Products (PP&P Magazine) and sponsored by NuAire, features microbiology expert Abby Roth discussing best practices for surface & air sampling, data analysis, and compliance.
Key Topics Covered:
鏝 Viable air & surface sampling best practices
鏝 USP <797> requirements & compliance strategies
鏝 How to analyze & trend viable sample data
鏝 Improving environmental monitoring in cleanrooms
・ Watch Now: https://www.nuaire.com/resources/best-sampling-practices-cleanroom-usp-797
Stay informedfollow Abby Roth on LinkedIn for more cleanroom insights!
Local Anesthetic Use in the Vulnerable PatientsReza Aminnejad
油
Local anesthetics are a cornerstone of pain management, but their use requires special consideration in vulnerable groups such as pediatric, elderly, diabetic, or obese patients. In this presentation, well explore how factors like age and physiology influence local anesthetics' selection, dosing, and safety. By understanding these differences, we can optimize patient care and minimize risks.
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxdrnidhimnd
油
The shoulder complex acts as in coordinated fashion to provide the smoothest and greatest range of motion possible of the upper limb.
Combined motion of GH and ST joint of shoulder complex helps in:
Distribution of motion between other two joints.
Maintenance of glenoid fossa in optimal position.
Maintenance of good length tension
Although some amount of glenohumeral motion may occur while the other shoulder articulations remain stabilized, movement of the humerus more commonly involves some movement at all three shoulder joints.
Non-Invasive ICP Monitoring for NeurosurgeonsDhaval Shukla
油
This presentation delves into the latest advancements in non-invasive intracranial pressure (ICP) monitoring techniques, specifically tailored for neurosurgeons. It covers the importance of ICP monitoring in clinical practice, explores various non-invasive methods, and discusses their accuracy, reliability, and clinical applications. Attendees will gain insights into the benefits of non-invasive approaches over traditional invasive methods, including reduced risk of complications and improved patient outcomes. This comprehensive overview is designed to enhance the knowledge and skills of neurosurgeons in managing patients with neurological conditions.
Invasive systems are commonly used for monitoring intracranial pressure (ICP) in traumatic brain injury (TBI) and are considered the gold standard. The availability of invasive ICP monitoring is heterogeneous, and in low- and middle-income settings, these systems are not routinely employed due to high cost or limited accessibility. The aim of this presentation is to develop recommendations to guide monitoring and ICP-driven therapies in TBI using non-invasive ICP (nICP) systems.
Unit 1: Introduction to Histological and Cytological techniques
Differentiate histology and cytology
Overview on tissue types
Function and components of the compound light microscope
Overview on common Histological Techniques:
o Fixation
o Grossing
o Tissue processing
o Microtomy
o Staining
o Mounting
Application of histology and cytology
1. Explain the physiological control of glomerular filtration and renal blood flow
2. Describe the humoral and autoregulatory feedback mechanisms that mediate the autoregulation of renal plasma flow and glomerular filtration rate
Flag Screening in Physiotherapy Examination.pptxBALAJI SOMA
油
Flag screening is a crucial part of physiotherapy assessment that helps in identifying medical, psychological, occupational, and social barriers to recovery. Recognizing these flags ensures that physiotherapists make informed decisions, provide holistic care, and refer patients appropriately when necessary. By integrating flag screening into practice, physiotherapists can optimize patient outcomes and prevent chronicity of conditions.
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...ABHAY INSTITUTION
油
Personality theory is a collection of ideas that explain how a person's personality develops and how it affects their behavior. It also seeks to understand how people react to situations, and how their personality impacts their relationships.
Key aspects of personality theory
Personality traits: The characteristics that make up a person's personality.
Personality development: How a person's personality develops over time.
Personality disorders: How personality theories can be used to study personality disorders.
Personality and environment: How a person's personality is influenced by their environment.
Stability of Dosage Forms as per ICH GuidelinesKHUSHAL CHAVAN
油
This presentation covers the stability testing of pharmaceutical dosage forms according to ICH guidelines (Q1A-Q1F). It explains the definition of stability, various testing protocols, storage conditions, and evaluation criteria required for regulatory submissions. Key topics include stress testing, container closure systems, stability commitment, and photostability testing. The guidelines ensure that pharmaceutical products maintain their identity, purity, strength, and efficacy throughout their shelf life. This resource is valuable for pharmaceutical professionals, researchers, and regulatory experts.
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVAN
油
This presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
2. ADVERSE DRUG REACTION
Any noxious change which is
Suspected to be due to a drug
At doses normally used in man
May requires treatment or decrease in dose or
Caution in the future use of the same drug
3. ADVERSE DRUG EVENT (ADE)
Any untoward occurrence that may present during medical
treatment,
But
Does not necessarily have a causal relationship with the
treatment
4. Incidence of ADR more
Polypharmacy
Elderly
Children
Patient with multiple diseases
Pregnancy
Malnourished
Immunosuppression
Drug Abusers and addicts
Develop
Immediately
or
Prolonged medication
or
After stopping.
5. GRADING OF SEVERITY OF ADVERSE DRUG REACTIONS :
Minor : No therapy, antidote or prolongation of
hospitalization is required.
Moderate: Requires change in drug therapy, specific
treatment or prolongs hospital stay.
Severe: Potentially life-threatening, causes permanent
damage or requires intensive medical treatment.
Lethal : Directly or indirectly contributes to death of the
patient.
6. CLASSIFICATIONS OF ADR
A (Augmented)
B (Bizarre)
C (Continuous)
D (Delayed)
E (Ending Use)
F (Failure of Efficacy)
Broadly
Type- A (Predictable)- Based on pharmacological properties
Type- B (Non-predictable) Based on Immunological response
and genetic makeup of person
7. TYPE A- AUGMENTED
These are based on the pharmacological properties of
the drug so can be predicted.
They are common and account for 75% of ADRs
Dose related and preventable mostly reversible.
Examples:-
Anticoagulants (e.g., warfarin, heparin) bleeding
Anti-hypertensives (e.g.. 留1-antagonists) hypotension
Anti-diabetics (e.g. insulin) - hypoglycemia
Predictable
8. TYPE B- BIZZARE OR UNPREDICTABLE
Have no direct relationship to the dose of the drug or the
pharmacological mechanism of drug action.
Develop on the basis of:
Immunological reaction on a drug (Allergy)
Genetic predisposition (Idiosyncratic reactions)
More serious clinical outcomes with higher mortality and morbidity.
Mostly require immediate withdrawal of the drug.
Un-predictable
9. TYPE C CHRONIC (CONTINOUS) USE
They are mostly associated with cumulative-long term
exposure
Example:-
Analgesic (NSAID) interstitial nephritis, papillary
sclerosis, necrosis
Predictable
10. TYPE D DELAYED
They manifest themselves with significant delay
Teratogenesis -Thalidomide Phocomelia (flipper-like fore limbs)
Mutagenesis/Cancerogenesis
Others:
Tardive dyskinesis during L-DOPA Parkinson disease
treatment
Predictable
11. TYPE E END OF USE
Drug withdrawal syndromes and rebound
phenomenons
Example sudden withdrawal of long term therapy with -
blockers can induce rebound tachycardia and
hypertension
Predictable
12. PHARMACOVIGILANCE (DAUP)
The 'science and activities relating to the detection,
assessment, understanding and prevention of adverse
effects or any other drug related problems
The information generated is useful in educating doctors and in
the official regulation of drug use.
It has an important role in rational use of medicines, as it
provides the basis for assessing safety of medicines.
13. Various activities involved in pharmacovigilance are:
Postmarketing surveillance and other methods of ADR
monitoring such as voluntary reporting by doctors prescription
event monitoring.
Dissemination of ADR data through 'drug alerts', 'medical
letters,' advisories sent to doctors by pharmaceuticals and
regulatory agencies.
Changes in the labelling of medicines indicating
restrictions in use or statuary warnings, precautions,
or even withdrawal of the drug.
14. The Uppsala Monitoring Centre (Sweden) is the international
collaborating centre.
In India,
National centre is located at Ghaziabad
Peripheral Centres at Medical college levels and tertiary and above
hospitals
Reports generated by doctors, paramedical staff--to peripheral
centre...National centre...Uppsala Monitoring Centre...Compilation of
data..analysis of data..causal association is confirmed..guidelines
issued regarding the safe use of medicine or (restricted use or
withdrawal from the market)
15. PREVENTION OF ADVERSE EFFECTS TO DRUGS
Avoid inappropriate use of drugs .
Appropriate drug administration (Rational Therapeutics)
Dose
Dosage form
Duration
Route
Frequency
Technique
Ask for previous history of drug reactions and allergies
Always suspect ADR when new symptom arises after initiation
of treatment. ( No new drug for new symptom).
Ask for laboratory findings like serum creatinine etc.
16. Categorized into:
Side effects-
Secondary effects
Toxic effects
Intolerance
Idiosyncrasy
Drug allergy
Photosensitivity
Drug dependence
Drug withdrawal reactions
Teratogenicity
Mutagenicity and Carcinogenicity
Drug induced diseases (Iatrogenic disorders or Iatrogenicity)
Beware of Iatrogenic, Idiosyncrasy, Idiopathic, Intolerance
17. SIDE EFFECTS
Unwanted often unavoidable Pharmaco-dynamic effects.
Occur at therapeutic doses.
Predictable
Examples.
Benzodiazepines- Motor in coordination
H1 Anti-histaminics- Sedation
An effect may be therapeutic in one context but side effect in another context
Depression of A-V conduction is the desired effect of digoxin in atrial
fibrillation, but the same may be undesirable when it is used for CHF.
Constipation by codeine is side effect but can be used as therapeutic effect in
patient with loose motions
18. SECONDARY EFFECTS
Indirect consequences of a primary action of the drug.
E.g. corticosteroids weaken host defence
mechanisms so that latent tuberculosis gets activated.
19. TOXIC EFFECTS (Poisonous effect)
It is the dose and duration which makes a poison.... Paracelsus
Over dose or prolonged use.
The effects are predictable and dose related.
The CNS, CVS, kidney, liver, lung, skin and bone marrow are
most commonly involved in drug toxicity.
20. Toxicity may result from extension of the therapeutic
effect itself, e.g. complete A-V block by digoxin, bleeding
due to heparin.
Poisoning: Poison is a substance which endangers life
by severely affecting one or more vital functions.
21. Specific antidotes such as receptor antagonists,
chelating agents or specific antibodies are available for
few poisons.
For others as well as for those poisons which have a
selective antagonist general supportive and
symptomatic treatment should be done.
These measures are:
1. Resuscitation and maintenance of vital functions:
maintenance of ABC , body temperature and blood
glucose.
2.Termination of exposure (decontamination)
3. Prevention of absorption of ingested poisons.
4. Hastening elimination of the poison by inducing
diuresis or altering urinary pH
22. INTOLERANCE
It is the appearance of characteristic toxic effects of
a drug in an individual at therapeutic doses
It indicates a low threshold of the individual to the
action of a drug
Example:- Only few doses of carbamazepine may
cause ataxia in some people
Un-Predictable
23. IDIOSYNCRASY
It is genetically determined abnormal reactivity to a
chemical.
The drug interacts with some unique feature of the individual,
not found in majority of subjects, and produces the
uncharacteristic reaction.
Example :-
Chloramphenicol produces nondose-related
serious aplastic anaemia in rare individuals.
Barbiturates cause excitement and mental confusion in some
individuals
Un-Predictable
24. DRUG ALLERGY
It is also called drug hypersensitivity.
It is an immunologically mediated reaction producing
stereotype symptoms which are unrelated to the
pharmacodynamic profile of the drug.
It generally occur even with much smaller doses and
have a different time course of onset and duration.
Un-Predictable
25. Allergic reactions occur only in a small proportion
of the population exposed to the drug .
History of prior sensitization may or may not be
evident.
The drug or its metabolite acts as antigen (AG) or
more commonly hapten (incomplete antigen) and
induce production of antibody (AB)/sensitized
lymphocytes.
26. TYPES OF ALLERGIC REACTIONS
A) HUMORAL
1. Type I/ anaphylactic reactions.
2. Type-II / cytolytic reactions.
3. Type-Ill / retarded or Arthus reactions.
B) CELL MEDIATED
Type-IV (delayed hypersensitivity) reactions.
27. PHOTOSENSITIVITY
It is a cutaneous reaction resulting from drug induced
sensitization of the skin to UV radiation.
The reactions are of two types:
a) Photo-toxic :- (T-S)
a) Drug or its metabolite Accumulates in the skin,
b) absorbs light and undergoes a Photochemical reaction followed by
c) Photobiological reaction resulting in
d) Tissue damage (sunburn-like),
a) i.e. erythema, edema, blistering , hyper pigmentation, desquamation.
The shorter wave lengths (290-320 nm, UVB) are responsible
28. (b) Photo-allergic: (A-L)
Drug or its metabolites induce a cell mediated immune response
which on exposure to
Light of longer wave lengths (320-400 nm, UV -A)
Produces a papular or eczematous contact dermatitis like picture.
Drugs involved are sulfonamides, sulfonylureas, griseofulvin,
chloroquine, chlorpromazine
29. DRUG DEPENDENCE
Use of drugs for personal satisfaction
Higher priority than other basic needs, often in the face of
known risks to health.
Physical dependence It is an altered physiological state
produced by repeated administration of a drug which
necessitates the continued presence of the drug to maintain
physiological equilibrium.
Discontinuation of the drug results in a characteristic
withdrawal (abstinence) syndrome.
Drugs producing physical dependence are opioids, barbiturates
and other depressants including alcohol and benzodiazepines
30. Drug abuse :
Refers to use of a drug by self medication in a manner and
amount that deviates from the approved medical and
social patterns in a given culture at a given time.
Drug addiction
It is a pattern of compulsive drug use characterized by
overwhelming involvement with the use of a drug.
Procuring the drug and using it takes precedence over
other activities
31. Drug habituation (Psychological dependence)
It denotes less intensive involvement with the drug, so that its
withdrawal produces only mild discomfort.
Consumption of tea, coffee, tobacco, social drinking are
regarded habituating, physical dependence is absent
32. DRUG WITHDRAWAL REACTIONS
Sudden interruption of therapy with certain other drugs results in
adverse consequences, mostly in the form of worsening of the
clinical condition for which the drug was being used
Example: Acute adrenal insufficiency may be precipitated by
abrupt cessation of corticosteroid therapy.
33. TERATOGENICITY (Teratos- Monster)
Drug to cause foetal abnormalities when administered to the
pregnant mother.
Drugs can affect the foetus at 3 stages-
(i) Fertilization and implantation-conception to
17 days-failure of pregnancy which often goes unnoticed.
(ii) Organogenesis-18 to 55 days of gestation most
vulnerable period, deformities are produced.
(iii) Growth and development-56 days onwards
developmental and functional abnormalities
can occur,
e.g. ACE inhibitors , Thalidomide, Warfarin,
Barbiturates,...............................
34. MUTAGENICITY AND CARCINOGENICITY
Cause genetic defects and cancer respectively.
Reactive intermediates which affect genes and may
cause structural changes in the chromosomes
Even without interacting directly with DNA, certain
chemicals can promote malignant change in genetically
damaged cells, resulting in carcinogenesis.
Examples- anticancer drugs, radioisotopes, estrogens,
tobacco...................................................
35. DRUG INDUCED DISEASES
These are also called iatrogenic (physician induced)
diseases, and are functional disturbances (disease)
caused by drugs .
Hepatitis by isoniazid and Rifampicin
Peptic ulcer by salicylates and corticosteroids
Retinal damage by chloroquine
36. MCQ ON ADR
Which of the following drugs is teratogenic in nature
Warfarin
Ampicillin
Paracetamol
Adrenaline
Warfarin
37. MCQ ON ADR
ADRs which are due to typical genetic make of
person are known as
Side Effects
Secondary Effects
Iatrogenic disorders
Idiosyncratic disorders
Iatrogenic disorders
38. MCQ ON ADR
Withdrawal symptoms are common in which of the following
drugs
Caffenine
Paracetamol
Opioids
Cocaine
Opioids
39. MCQ ON ADR
The most dangerous period regarding teratogenic effect is
First trimester
Second trimester
Third trimester
Early neonatal life
First Trimester
40. MCQ ON ADR
International collaborating centre of Pharmacovigilance is
situated at
United States of America
Australia
Sweden
United Kingdom
Sweden